瓜薤心通滴丸治疗慢性稳定型心绞痛(痰瘀阻络证)多中心、随机、双盲、不同剂量平行对照的II期探索性研究
[Translation] A phase II exploratory study of Guaxiexintong dripping pills in the treatment of chronic stable angina pectoris (phlegm and blood stasis obstruction syndrome) with multicenter, randomized, double-blind, and parallel control at different doses
(1)探索瓜薤心通滴丸治疗慢性稳定型心绞痛的适宜剂量;
(2)初步评价瓜薤心通滴丸治疗慢性稳定型心绞痛的有效性及安全性。
[Translation] (1) To explore the appropriate dose of Guaxiexintong dripping pills for the treatment of chronic stable angina pectoris;
(2) To preliminarily evaluate the efficacy and safety of Guaxiexintong dripping pills in the treatment of chronic stable angina pectoris.
100 Clinical Results associated with Beijing Hurun Innovative Pharmaceutical Technology Development Co., Ltd.
0 Patents (Medical) associated with Beijing Hurun Innovative Pharmaceutical Technology Development Co., Ltd.
100 Deals associated with Beijing Hurun Innovative Pharmaceutical Technology Development Co., Ltd.
100 Translational Medicine associated with Beijing Hurun Innovative Pharmaceutical Technology Development Co., Ltd.